NDC 0409-1810 - Novocaine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0409-1810
Package NDCs from labels: 0409-1810-02
Manufacturer: Hospira, Inc.
Effective date: 2007-08-28
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP	Hospira, Inc.	2007-08-28	Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0409-1810-02	Novocaine	25 in 1 CARTON	INJECTION, SOLUTION	25	2
0409-1810-02	Novocaine	5 in 1 CONTAINER	INJECTION, SOLUTION	5	2
0409-1810-02	Novocaine	40 in 1 CASE	INJECTION, SOLUTION	40	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-1810	NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2	3 package rows	20070914_999625D5-3A6B-4753-059A-4F19D04C85A5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Procaine Hydrochloride	ACTIVE INGREDIENT	95URV01IDQ	NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2
Procaine	ACTIVE MOIETY	4Z8Y51M438	NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2
Acetone Sodium Bisulfite	INACTIVE INGREDIENT		NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 9 · 177 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Nalbuphine Hydrochloride	NALBUPHINE HYDROCHLORIDE	Hospira, Inc.	6025e8d4-5083-4c3a-58a0-050e7b0b6150	2025-12-31	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
VinCRIStine Sulfate	VINCRISTINE SULFATE	Hospira, Inc.	49596de6-ab18-49d1-9e5b-30968fc21c36	2025-12-30	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Regadenoson	REGADENOSON	Hospira, Inc.	0e3f080d-b1fb-47ed-8cd3-90a4206fa704	2025-12-08	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Ondansetron	ONDANSETRON	Hospira, Inc.	e0862c02-781f-4b10-ae50-9c9c4ca26f6d	2025-12-01	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Metronidazole	METRONIDAZOLE	Hospira, Inc.	49360d6f-c8b3-420e-af75-154cf7b05255	2025-11-19	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
SODIUM CHLORIDE	SODIUM CHLORIDE	Hospira, Inc.	af6aebad-ef03-4d19-9a40-18e5a278b812	2025-11-11	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Bicarbonate	SODIUM BICARBONATE	Hospira, Inc.	ea20a5eb-641e-48cd-bcfa-74c04c45dfda	2025-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Ciprofloxacin in Dextrose	CIPROFLOXACIN	Hospira, Inc.	cbbbf939-3219-4515-a48e-ca264daa4d07	2025-11-04	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Irinotecan Hydrochloride	IRINOTECAN HYDROCHLORIDE	Hospira, Inc.	5c527c2e-9062-4afe-dbbb-f650db3a340f	2025-11-03	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Erythrocin Lactobionate	ERYTHROMYCIN LACTOBIONATE	Hospira, Inc.	a96c405f-bd70-4bb4-719e-ac6a79dcc213	2025-10-30	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
PEMETREXED	PEMETREXED	Hospira, Inc.	3ae68628-7ab0-4491-b3ae-6a8330b719c8	2025-10-08	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Potassium Phosphates	POTASSIUM PHOSPHATES	Hospira, Inc.	2fcbc814-c7a4-469a-8b1d-6819b961bfb9	2025-09-30	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
MILRINONE LACTATE	MILRINONE LACTATE	Hospira, Inc.	813e8ca2-de54-4a7c-a2d2-8bd44396c341	2025-09-26	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Methotrexate	METHOTREXATE	Hospira, Inc.	0e30eaef-5a09-4104-8a11-c32933eadeab	2025-08-22	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Testosterone Cypionate	TESTOSTERONE CYPIONATE	Hospira, Inc.	6909596e-4bf7-4e11-8029-b89740a30aec	2025-08-22	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Mitoxantrone	MITOXANTRONE	Hospira, Inc.	accf9569-4b57-4e83-a7db-4e890a75d1ba	2025-07-14	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Methotrexate	METHOTREXATE	Hospira, Inc.	bd287e89-32f9-4396-95fa-4b562869f476	2025-06-30	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
LEVOPHED	NOREPINEPHRINE BITARTRATE	Hospira, Inc.	2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10	2025-06-12	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
LEVOPHED	NOREPINEPHRINE BITARTRATE	Hospira, Inc.	c4de72a8-2a75-4984-ce90-e4870226dc12	2025-06-12	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Methotrexate	METHOTREXATE	Hospira, Inc.	0d63ba29-b692-41b4-87e8-351265c8273f	2025-06-10	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.